Cargando…

Therapeutic Genome Editing in Cardiovascular Diseases

A variety of genetic cardiovascular diseases may one day be curable using gene editing technology. Germline genome editing and correction promises to permanently remove monogenic cardiovascular disorders from the offspring and subsequent generations of affected families. Although technically feasibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	German, David M., Mitalipov, Shoukhrat, Mishra, Anusha, Kaul, Sanjiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	STATE-OF-THE-ART REVIEW
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390678/ https://www.ncbi.nlm.nih.gov/pubmed/30847427 http://dx.doi.org/10.1016/j.jacbts.2018.11.004

Ejemplares similares

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

Small non-coding RNA therapeutics for cardiovascular disease
por: Shah, Ajay M, et al.
Publicado: (2022)

Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing
por: Wang, Xiao, et al.
Publicado: (2019)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

The Multifunctional Protein BAG3: A Novel Therapeutic Target in Cardiovascular Disease
por: Myers, Valerie D., et al.
Publicado: (2018)

Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets
por: Schultz, Taylor I., et al.
Publicado: (2022)

Strategy of Patient-Specific Therapeutics in Cardiovascular Disease Through Single-Cell RNA Sequencing
por: Jung, Yunseo, et al.
Publicado: (2022)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

Ten things to know about ten cardiovascular disease risk factors
por: Bays, Harold E., et al.
Publicado: (2021)

Ten things to know about ten cardiovascular disease risk factors – 2022
por: Bays, Harold E, et al.
Publicado: (2022)

Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
por: Robinson, Emma Louise, et al.
Publicado: (2022)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Immunometabolism at the Heart of Cardiovascular Disease
por: DeBerge, Matthew, et al.
Publicado: (2023)

Summarizing 2019 in Cardiovascular Prevention using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach
por: Feldman, David I., et al.
Publicado: (2020)

Climate change and the prevention of cardiovascular disease
por: Jacobsen, Alan P., et al.
Publicado: (2022)

Epidemiological Features of Cardiovascular Disease in Asia
por: Zhao, Dong
Publicado: (2021)

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
por: Hendren, Nicholas S., et al.
Publicado: (2020)

Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
por: Dimopoulos, Konstantinos, et al.
Publicado: (2023)

Historical epistemology of the body-mind interaction in psychiatry
por: Berrios, German E.
Publicado: (2018)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Single-cell technologies to decipher cardiovascular diseases
por: Abplanalp, Wesley Tyler, et al.
Publicado: (2022)

Oral health and atherosclerotic cardiovascular disease: A review
por: Gianos, Eugenia, et al.
Publicado: (2021)

Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
por: Need, Anna C., et al.
Publicado: (2016)

Innate Immune Receptors, Key Actors in Cardiovascular Diseases
por: Jaén, Rafael I., et al.
Publicado: (2020)

Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
por: Arafa, Ahmed, et al.
Publicado: (2021)

Telomeres as Therapeutic Targets in Heart Disease
por: Yeh, Jih-Kai, et al.
Publicado: (2019)

Designer Approaches for G Protein–Coupled Receptor Modulation for Cardiovascular Disease
por: Grisanti, Laurel A., et al.
Publicado: (2018)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease( )
por: van Smeden, Maarten, et al.
Publicado: (2022)

Therapeutic apheresis in kidney diseases: an updated review
por: Chen, Yi-Yuan, et al.
Publicado: (2022)

Limitation of the therapeutic effort: ethical and legal justification for withholding and/or withdrawing life sustaining treatments
por: Borsellino, Patrizia
Publicado: (2015)

Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)

Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology
por: Javaid, Aamir, et al.
Publicado: (2022)

The Johns Hopkins Ciccarone Center's expanded ‘ABC's approach to highlight 2020 updates in cardiovascular disease prevention
por: Feldman, David I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67qo7smn2b8uav8np807dre3oa